# MarketFlow Expectancy Backtest Lab Results Review Status

## Status

- Artifact: `MARKETFLOW_EXPECTANCY_BACKTEST_LAB_RESULTS_REVIEW_PACKAGE`.
- Status: `MARKETFLOW_EXPECTANCY_BACKTEST_LAB_RESULTS_REVIEW_PACKAGE_READY`.
- Scope: `EXPECTANCY_BACKTEST_LAB_RESULTS_REVIEW_ONLY_NOT_REASSESSMENT_NOT_RUNTIME`.
- Source execution digest: `7c97920ef7cc98ef971f5cee3838a250b0cb2d217656567897516d7767f4101d`.
- Output binding digest: `a2b505a2fee0a42506350397bcc6a700a92d58ab8a9d522ffdfa5a2fd04e8086`.

## Offline Output Review

The review inspects the fourteen ignored expectancy-lab outputs read-only, verifies every ordinary file hash, validates the digest-manifest self-reference policy, and streams `expectancy_backtest_rows.jsonl` without loading the corpus into memory. Source hashes are checked before and after inspection to ensure the outputs remain unchanged.

The review verifies 179,190 lab rows, 177,090 available target outcomes, 2,100 unavailable outcomes, 4,200 retained cross-split embargo rows, and 172,890 aggregate-metric-eligible rows. All six approved baselines and thirteen approved descriptive metric families are present. The randomized-null baseline and bootstrap metric remain blocked.

## No-Peek and Dataset Boundaries

Target values/classes remain outcome fields only. Future returns, predictions, strategy scores, recommendations, broker/order fields, provider payloads, and API-key fields are absent from predictor-like structures. Chronological no-shuffle and horizon-aware embargo controls are preserved.

The exact ordered twelve-ticker universe and 11,946 canonical records remain bound. META remains exactly 913 historical records and 13,695 lab rows without repair, smoothing, inference, or fabrication.

## Authority Boundary

The review marks only readiness for a future predictive-usefulness reassessment. It does not create that reassessment, acceptance readiness, an acceptance candidate, model training, strategy scoring, recommendations, predictive-usefulness or profitability acceptance, runtime migration, paper trading, or broker execution authority. No provider, acquisition, regeneration, or source-stage rerun occurs.

## Next Task

Predictive-Usefulness Reassessment Using Expectancy Lab Evidence v1 is implemented as the offline, digest-bound follow-on. This results review remains immutable source evidence, and the reassessment uses only the reviewed expectancy-lab evidence and committed bindings. It does not create an acceptance-readiness review, acceptance candidate, recommendations, predictive-usefulness or profitability acceptance, runtime authority, paper trading, or broker execution.
